SPL
TYRA icon

Superior Planning, LLC’s Tyra Biosciences TYRA Stock Holding History

Superior Planning, LLC’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$416 Buy
+19
New +$522 ﹤0.01% 1922

Other funds holding TYRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Canaan Partners XI
Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Superior Planning, LLC's TYRA Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Tyra Biosciences (TYRA) in Q3 2026: 19 shares worth $416. The stake represents ﹤0.01% of the portfolio and ranks #1922 among its holdings.

74 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Superior Planning, LLC held 19 shares of Tyra Biosciences worth $416 as of Q3 2026.
  • Tyra Biosciences was a new Superior Planning, LLC position in Q3 2026.
  • Tyra Biosciences made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1922 holding.
  • 74 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.